A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.

Zhao J, Hu Y, Zhu Y, Wu B, Hu M, Li M, Liang Y, Li J, Qiao G, Fan X, Yan H, Wang X, Zheng Z, Zhang X, Li J, Lou T, Ma Y.

Open source

DOI: 10.1111/hex.70652
Published: 2026-04-01
Container: Health Expect
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/hex.70652,
  title = {A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.},
  author = {Zhao J and  Hu Y and  Zhu Y and  Wu B and  Hu M and  Li M and  Liang Y and  Li J and  Qiao G and  Fan X and  Yan H and  Wang X and  Zheng Z and  Zhang X and  Li J and  Lou T and  Ma Y.},
  year = {2026},
  journal = {Health Expect},
  doi = {10.1111/hex.70652},
  url = {https://doi.org/10.1111/hex.70652}
}

RIS

TY  - JOUR
TI  - A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.
AU  - Zhao J
AU  -  Hu Y
AU  -  Zhu Y
AU  -  Wu B
AU  -  Hu M
AU  -  Li M
AU  -  Liang Y
AU  -  Li J
AU  -  Qiao G
AU  -  Fan X
AU  -  Yan H
AU  -  Wang X
AU  -  Zheng Z
AU  -  Zhang X
AU  -  Li J
AU  -  Lou T
AU  -  Ma Y.
PY  - 2026
JO  - Health Expect
DO  - 10.1111/hex.70652
UR  - https://doi.org/10.1111/hex.70652
ER  -

APA

J, Z., Y, H., Y, Z., B, W., M, H., M, L., Y, L., J, L., G, Q., X, F., H, Y., X, W., Z, Z., X, Z., J, L., T, L., & Y., M. (2026). A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China.. Health Expect. https://doi.org/10.1111/hex.70652

Source records

europe-pmc · retrieved 2026-09-25T03:36:42.900Z
doaj · retrieved 2026-09-25T03:36:42.870Z